drugset / Trial / NCT05533788
ABSK091 Food Effect Study in Healthy Subjects
RandomizedCrossoverDouble-blindOther
Summary
In this study, a single oral dose of the tablet formulation administered under fed conditions will be compared to administration under fasted conditions to assess the effects of a high-fat meal on the rate and extent of absorption and exposure. Study ABSK091-101 is a single-center, Phase 1, open-label, randomized, two-period, two-sequence, and crossover study in healthy subjects.
Timeline
- Start
- 2020-09-08
- Primary completion
- 2021-04-30
- Completion
- 2021-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexagratinib | Small molecule | — | Oral |
Indications
No indication recorded.